Samsara Therapeutics

company

About

Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$10.31M
Industries
Biopharma,Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Samsara Therapeutics, Inc. is an R&D-stage biopharmaceutical platform company aiming to discover, develop and commercialize therapeutics for the treatment of unmet medical needs and age-related diseases. Samsara's platform is a pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10.31M
Samsara Therapeutics has raised a total of $10.31M in funding over 2 rounds. Their latest funding was raised on Jul 15, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 15, 2021 Series A $10.31M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Samsara Therapeutics is funded by 1 investors. Korify Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Korify Capital Series A